Skip to main content
Equibles

Man Group plc

Position in ZYME — Zymeworks Inc.

CIK 1637460 LONDON, X0
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,509,763
+$754,918 QoQ
Shares Held
210,779
+11.0% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 202 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority Sole 77% Shared 0% None 23%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,100,351,284 across 114 Biotechnology names. ZYME ranks #30 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 436,956 $272,459,544
2 INCY
Incyte Corp
 952,941 $108,025,391
3 ONC
BeOne Medicines Ltd.
 307,463 $87,617,731
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 139,233 $69,161,207
5 APGE
Apogee Therapeutics, Inc.
 397,000 $52,693,809
6 ALNY
Alnylam Pharmaceuticals, Inc.
 170,907 $51,448,133
7 JAZZ
Jazz Pharmaceuticals plc
 152,877 $36,838,770
8 RVMD
Revolution Medicines, Inc.
 173,439 $32,481,655

All Filings in ZYME

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,509,763 210,779
2026-03-31 $4,754,845 189,890
2025-12-31 $1,983,122 75,318
2025-09-30 $2,709,161 158,616
2025-06-30 $444,345 35,406
2025-03-31 $129,330 10,859
2024-03-31 $416,413 39,583
2023-12-31 $444,369 42,769
2023-09-30 $158,963 25,073
2023-06-30 $194,520 22,514
2023-03-31 $112,259 12,418
2022-12-31 $143,751 18,289